Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD

Clinical trial NCT02022540 · COMPLETED

Trial details

NCT number: NCT02022540
Sponsor: PanOptica, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Age-Related Macular Degeneration (AMD)

Start date: 2014-02-01
Primary completion: 2016-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.